Highlights
NASDAQ: CTMX       Cytomx Thera
Last Price Today's Change   Day's Range   Trading Volume
6.62   -0.15 (2.22%)  6.52 - 6.78  313,000

Overview

 
Avg Volume (4 weeks):371,250
4 Weeks Range:6.43 - 7.21
4 Weeks Price Volatility (%):
24.36%
52 Weeks Range:3.595 - 15.44
52 Weeks Price Volatility (%):
25.54%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platform. The company probody technology platform to create proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of unique conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues. The company focuses on developing Probody therapeutics which addresses clinically-validated cancer targets in immuno-oncology that are difficult to drug and lead to concerns about damage to healthy tissues or toxicities.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3337  5213  557  159 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 BLRX 1.98+0.50 
 AAPL 108.86-6.46 
 NIO 30.58-1.41 
 SQQQ 25.03+1.67 
 SPY 326.54-3.44 
 GE 7.42+0.05 
 TWTR 41.36-11.07 
 F 7.73-0.17 
 CCL 13.71+0.73 
 OAS 0.155-0.014